Research summary, original research, 2026

Analysis of abnormal results in personal dose monitoring of radiation workers in Beijing, China from 2021 to 2025

Qingxiang T, Limeng C, Yongzhong M, Wenwen J, Bin B. Radiation protection dosimetry. 2026

Read the original paper

In plain language

In five years of Beijing dose monitoring records, most readings above the investigation level reflected dosimeter misuse rather than real exposure. Among the 46 confirmed exposures, interventional radiology staff had the highest share and largest collective dose.

At a glance

Type of study
Original research, Retrospective cohort study
Who was studied
Mixed lab staff, Interventional radiologists
Size
n = 286,339 person-times of dose monitoring
Where
China
Summary based on
the abstract

What it found

  • Interventional radiology personnel had the highest actual exposure fraction, the highest proportion of exposed individuals and the largest collective dose among worker groups.

  • Improper dosimeter placement and wearing were the main causes of false abnormal doses, accounting for most over-threshold records.

  • Only 46 of 313 over-threshold records were confirmed as actual occupational exposure, all below 3 mSv per quarter.

    Key figures: 46 of 313 records; all <3 mSv quarterly

  • The overall 5-year rate of records above the 1.25 mSv quarterly investigation level was 0.11%, with no significant annual variation.

    Key figures: 0.11% (313 of 286 339 person-times)

  • Abnormal cases were concentrated in medical institutions, especially diagnostic and interventional radiology.

Limits to keep in mind

Retrospective analysis of regional monitoring records based on an abstract only; dosimeter misuse may also cause under-reading, and group-level numbers for interventional staff are not given in the abstract.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.